Boxed warnings for dermatologic JAK inhibitors: are they standardized worldwide?

IF 2.9 4区医学 Q2 DERMATOLOGY Journal of Dermatological Treatment Pub Date : 2024-09-18 DOI:10.1080/09546634.2024.2403710

Shayla Nguyen, Nicholas Brownstone, John Koo

引用次数: 0

Abstract

Published in Journal of Dermatological Treatment (Vol. 35, No. 1, 2024)

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

皮肤病用 JAK 抑制剂的盒装警告：是否在全球范围内统一？

发表于《皮肤病治疗杂志》（第 35 卷第 1 期，2024 年）

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Dermatological Treatment 医学-皮肤病学

CiteScore

6.50

自引率

0.00%

发文量

145

审稿时长

6-12 weeks

期刊介绍： The Journal of Dermatological Treatment covers all aspects of the treatment of skin disease, including the use of topical and systematically administered drugs and other forms of therapy. The Journal of Dermatological Treatment is positioned to give dermatologists cutting edge information on new treatments in all areas of dermatology. It also publishes valuable clinical reviews and theoretical papers on dermatological treatments.

期刊最新文献

Boxed warnings for dermatologic JAK inhibitors: are they standardized worldwide? A review of biosimilars in psoriasis: impacts on efficacy, safety, access, and a first-hand look at biosimilar cost savings within the department of veterans affairs Postoperative risk assessment of post-inflammatory hyperpigmentation and the efficacy of delayed prevention following 532 nm Q-switched Nd:YAG laser treatment of solar lentigines: a randomized controlled study. Biodegradable polymers and platelet-rich plasma causing visual impairment: a literature review. Exploring the effect of deucravacitinib in patients with palmoplantar pustular psoriasis.